Reverse-Engineer a Reference Curve: Capturing Tabular Data From Graphical Output

Developing and marketing a new compound can not only involve demonstrating efficacy against placebo, but also against other compounds In an industry typified by active research programs and a steady stream of new data, planned analyses are often supplemented by unplanned and ad hoc comparisons against newly-published Information Such comparisons are often hindered by the absence or non-availability of raw or electronic data for the competitor drug.

Provided by: SAS Institute Topic: Data Management Date Added: Mar 2010 Format: PDF

Download Now

Find By Topic